Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.190
-0.140 (-10.53%)
At close: May 22, 2026, 4:00 PM EDT
1.955
+0.765 (64.29%)
After-hours: May 22, 2026, 7:59 PM EDT

Artelo Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.270.62.342.826.896.63
Short-Term Investments
---7.6110.653.44
Cash & Short-Term Investments
10.270.62.3410.4317.5310.07
Cash Growth
1277.08%-74.34%-77.58%-40.53%74.20%-
Other Current Assets
0.150.10.220.550.790.25
Total Current Assets
10.420.72.5610.9818.3210.32
Net Property, Plant & Equipment
0.060.060.10.020.060.09
Other Intangible Assets
2.042.042.042.042.042.04
Other Long-Term Assets
000000.19
Total Assets
12.522.84.713.0420.4212.64
Accounts Payable
4.043.041.681.240.910.47
Accrued Expenses
0.040.02----
Short-Term Debt
0.660.61----
Current Portion of Leases
0.040.040.040.020.040.03
Other Current Liabilities
1.050.350.060.030.050.03
Total Current Liabilities
5.834.041.771.2910.53
Long-Term Leases
0.020.030.07-0.020.07
Total Long-Term Liabilities
0.020.030.07-0.020.07
Total Liabilities
5.854.071.841.291.020.59
Common Stock
---000
Additional Paid-in Capital
72.8962.0153.1952.2650.6828.93
Accumulated Other Comprehensive Income
-0.25-0.27-0.2-0.2-0.250.02
Retained Earnings
-65.97-63.02-50.14-40.31-31.02-16.9
Shareholders' Equity
6.67-1.272.8611.7519.412.04
Total Liabilities & Equity
12.522.84.713.0420.4212.64
Total Debt
0.720.680.10.020.060.1
Net Cash (Debt)
9.55-0.082.2310.417.479.97
Net Cash Growth
---78.53%-40.45%75.23%-
Net Cash Per Share
16.60-0.2312.4863.18111.0021.21
Book Value
6.67-1.272.8611.7519.412.04
Book Value Per Share
11.59-3.7115.9671.37123.2825.62
Tangible Book Value
4.63-3.310.829.7117.3610
Tangible Book Value Per Share
8.05-9.654.5758.99110.3321.28
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q